(Q47581564)

English

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center

scientific article published in November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

granulomatosis with polyangiitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Rodrigo Cartin-Ceba

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Jason M Golbin

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Karina A Keogh

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Tobias Peikert

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Marta Sánchez-Menéndez

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Steven R Ytterberg

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Fernando C Fervenza

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Ulrich Specks

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

publication date

1 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

64

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

3770-3778

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Etanercept plus standard therapy for Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions.

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement--a prospective, open-label pilot trial.

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Effect of chemotherapeutic agents on natural and BCG-stimulated macrophage cytotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Regulatory roles for cytokine-producing B cells in infection and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Pneumocystis pneumonia

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Pneumocystis carinii infection in transgenic B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Rituximab-associated neutropenia

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Serum immunoglobulins and risk of infection: how low can you go?

1 reference

https://api.crossref.org/works/10.1002%2FART.34584

21 January 2018

Identifiers

10.1002/ART.34584

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22730028

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47581564&oldid=2160647692"